Literature DB >> 21888756

Asthma programmes in diverse regions of the world: challenges, successes and lessons learnt.

U G Lalloo1, R D Walters, M Adachi, T de Guia, A Emelyanov, C C Fritscher, J Hong, C Jimenez, G G King, J Lin, A Loaiza, G Nadeau, H Neffen, B E Sekerel, A Yorgancioğlu, H J Zar.   

Abstract

International surveys have demonstrated that asthma is still underdiagnosed and undertreated in many parts of the world. Despite improvements in the standard of asthma care delivered in many areas, as evidenced by improved global asthma mortality data, much information on projects and programmes undertaken in resource-limited regions of the world is not in the public domain. The aim of this report is to review projects and programmes in diverse regions around the world so that health care providers, planners and consumers may draw on the successes, failures and lessons learnt. Such real world experiences may contribute to achieving Global Initiative for Asthma goals of asthma control. Asthma projects and programmes in Argentina, Australia, Brazil, China, Japan, Mexico, Philippines, Russia, South Africa and Turkey were discussed by a group of experts in asthma care, the Advancing Asthma Care Network, from their respective countries, over a course of three satellite meetings in 2010. Collective analyses consistently identified low rates of dissemination and implementation of national and international treatment guidelines, low levels of continuing medical education and training of primary health care professionals and access and distribution of inhaled corticosteroids to be major barriers that are critical to the overall success of a national asthma management programme. In the less developed asthma programmes, under-recognition and undertreatment further limited the success of the programmes. Evidence from well-established national asthma management programmes suggests that establishment of a successful programme entails a logical progression through specific developmental stages, starting with political/stakeholder endorsement and commitment, followed by epidemiological evaluation, evaluation of disease burden, evaluation of access to care and best therapy, and finally optimisation and maintenance therapy for individual patients.

Entities:  

Mesh:

Year:  2011        PMID: 21888756     DOI: 10.5588/ijtld.11.0289

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  15 in total

1.  Challenges in treating pediatric asthma in developing countries.

Authors:  Heather J Zar; Michael E Levin
Journal:  Paediatr Drugs       Date:  2012-12-01       Impact factor: 3.022

2.  Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.

Authors:  Eric D Bateman; David B Price; Hao-Chien Wang; Adel Khattab; Patricia Schonffeldt; Angelina Catanzariti; Ralf J P van der Valk; Maarten J H I Beekman
Journal:  Eur Respir J       Date:  2022-05-05       Impact factor: 33.795

3.  Educational and decision-support tools for asthma-management guideline implementation.

Authors:  Sae-Hoon Kim; Sang-Heon Cho
Journal:  Asia Pac Allergy       Date:  2012-01-31

4.  Indian guidelines for asthma: Adherence is the key.

Authors:  Parvaiz A Koul; Dharmesh Patel
Journal:  Lung India       Date:  2015-04

Review 5.  Effectiveness of computerized clinical decision support systems for asthma and chronic obstructive pulmonary disease in primary care: a systematic review.

Authors:  Mariam Fathima; David Peiris; Pradnya Naik-Panvelkar; Bandana Saini; Carol Lyn Armour
Journal:  BMC Pulm Med       Date:  2014-12-02       Impact factor: 3.317

6.  Appropriateness of chronic asthma management and medication adherence in patients visiting ambulatory clinic of Gondar University Hospital: a cross-sectional study.

Authors:  Zelalem Tilahun Tesfaye; Nebeyu Tsegu Gebreselase; Boressa Adugna Horsa
Journal:  World Allergy Organ J       Date:  2018-08-10       Impact factor: 4.084

7.  Socio-economic dynamics of asthma.

Authors:  Surya Kant
Journal:  Indian J Med Res       Date:  2013-10       Impact factor: 2.375

8.  Are pharmacological randomised controlled clinical trials relevant to real-life asthma populations? A protocol for an UNLOCK study from the IPCRG.

Authors:  Karin Lisspers; Pedro Teixeira; Coert Blom; Janwillem Kocks; Björn Ställberg; David Price; Niels Chavannes
Journal:  NPJ Prim Care Respir Med       Date:  2016-04-14       Impact factor: 2.871

9.  Burden of asthma, dyspnea, and chronic cough in South Asia.

Authors:  Ghose Bishwajit; Shangfeng Tang; Sanni Yaya; Zhanchun Feng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-06

10.  The virtual asthma guideline e-learning program: learning effectiveness and user satisfaction.

Authors:  Sung-Yoon Kang; Sae-Hoon Kim; Yong-Eun Kwon; Tae-Bum Kim; Hye-Kyung Park; Heung-Woo Park; Yoon-Seok Chang; Young-Koo Jee; Hee-Bom Moon; Kyung-Up Min; Sang-Heon Cho
Journal:  Korean J Intern Med       Date:  2017-07-21       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.